Metabolic Changes Induced by Genetically Modified Potatoes
August 24, 2009 updated by: Charite University, Berlin, Germany
Starches from genetically modified potatoes, which differed in terms of amylose, amylopectin and phosphate content, were tested in a human randomized controlled trial.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 12200
- Recruiting
- Charité, Dept. of Endocrinology, Diabetes and Nutrition
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- healthy males
Exclusion Criteria:
- no acute oder severe chronic diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Starch 1
|
Starch from genetically modified potatoes
|
|
Other: Starch 2
|
Starch from genetically modified potatoes
|
|
Other: Starch 3
|
Starch from genetically modified potatoes
|
|
Other: Starch 4
|
Starch from genetically modified potatoes
|
|
Other: Starch 5
|
Starch from genetically modified potatoes
|
|
Other: Starch 6
|
Starch from genetically modified potatoes
|
|
Other: Starch 7
|
Starch from genetically modified potatoes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Glucose metabolism
Time Frame: 2 days
|
2 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2007
Primary Completion (Actual)
July 1, 2009
Study Completion (Anticipated)
December 1, 2009
Study Registration Dates
First Submitted
August 5, 2009
First Submitted That Met QC Criteria
August 5, 2009
First Posted (Estimate)
August 6, 2009
Study Record Updates
Last Update Posted (Estimate)
August 25, 2009
Last Update Submitted That Met QC Criteria
August 24, 2009
Last Verified
August 1, 2009
More Information
Terms related to this study
Other Study ID Numbers
- EA4/069/07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.